BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Encelle, Inc. Completes Diabetic Foot Ulcer Clinical Trial And Presents Data At National Wound Care Meetings


10/19/2005 5:10:00 PM

RALEIGH, N.C., May 18 /PRNewswire/ -- Encelle, Inc. has successfully completed a second human clinical trial for E-Matrix(tm) treatment of diabetic foot ulcers. This controlled, randomized fifty-six patient feasibility study provides the data necessary to design the next pre-market (pivotal) clinical trial, and preliminary safety and efficacy results.

Dr. Jason Hanft (South Miami, Fla.) the top enroller in the study said, "This novel approach to healing diabetic foot ulcerations demonstrated the potential to improve healing rates with excellent safety. A pivotal trial is necessary to fully explore this potential for an interesting new treatment for a difficult disease state."

Abstracts of the results have been accepted for platform presentations at two national wound healing meetings. Dr. Hanft presented the initial clinical trial results at the Society for Advanced Wound Care annual meeting in San Diego, Calif. in April. On May 20th, Dr. William A. Marston (UNC, Chapel Hill, N.C.) will provide additional results at the annual Wound Healing Society meeting in Chicago, Ill.

About Encelle, Inc.

Encelle, Inc. ( http://www.encelle.com/ ) has developed and patented products with broad therapeutic applications, including advanced wound repair, hard and soft tissue repair for orthopedics, and cosmesis. The company is headquartered in Raleigh, N.C., with research and pilot production facilities in Greenville, N.C.

CONTACT: Jim Woodward, CEO Encelle, Inc. 919/877-8101

Encelle, Inc.

CONTACT: Jim Woodward, CEO of Encelle, Inc., +1-919-877-8101



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES